0 (0%)		11-11 17:42
Open: High: Volume: 0		Pre. Close: Low: Market Cap: 0(M)

Short term
Mid term
Targets	6-month :	0.37	1-year :	0.5
Resists	First :	0.31	Second :	0.42
Pivot price	0.18
Supports	First :	0.14	Second :	0.11
MAs	MA(5) :	0.19	MA(20) :	0.21
	MA(100) :	0.38	MA(250) :	0.77
MACD	MACD :	-0.1	Signal :	-0.1
%K %D	K(14,3) :	23.2	D(3) :	25.7
RSI	RSI(14): 40.3
52-week	High :	1.52	Low :	0.14

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ CNTG ] has closed above bottom band by 27.5%. Bollinger Bands are 1.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	0.14 - 0.14	0.14 - 0.14
Low:	0.14 - 0.14	0.14 - 0.14
Close:	0.14 - 0.14	0.14 - 0.14

Mon, 31 Mar 2025
From CNTG to CSNMG2, a big step on a journey of letters and numbers - Pacific Navy News - Pacific Navy News

Wed, 12 Mar 2025
CENTOGENE Finalizes Private Equity Buyout: What Shareholders Need for Liquidation Payout - Stock Titan

Wed, 13 Nov 2024
CENTOGENE Sells Operating Assets for €8.7M to Charme Capital, Plans Liquidation - Stock Titan

Tue, 14 May 2024
CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease - Stock Titan

Tue, 04 Jul 2023
OTUWA Condoles Guinean Labour Movement On Death of Foremost Woman Labour Leader, Comrade Rabiatou Serah Diallo - intervention.ng

Tue, 27 Jun 2023
CENTOGENE and Lifera, a Biopharma Company Owned by the PIF, Enter Strategic Collaboration – Forming Saudi Arabian Joint Venture to Increase Access to Leading Data-Driven Multiomic Testing and Securing CENTOGENE $30 Million Investment - Stock Titan

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange:
Sector:
Industry:
Shares Out	29 (M)
Shares Float	12 (M)
Held by Insiders	4.5 (%)
Held by Institutions	66.8 (%)
Shares Short	82 (K)
Shares Short P.Month	126 (K)

EPS	-1.39
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	-0.88
Profit Margin	-73.3 %
Operating Margin	-63.3 %
Return on Assets (ttm)	-26.8 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	-8.4 %
Gross Profit (p.s.)	0
Sales Per Share	1.67
EBITDA (p.s.)	-1.14
Qtrly Earnings Growth	0 %
Operating Cash Flow	-32 (M)
Levered Free Cash Flow	-23 (M)

PE Ratio	-0.11
PEG Ratio	0
Price to Book value	-0.17
Price to Sales	0.08
Price to Cash Flow	-0.13

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.